FilingReader Intelligence
Biocon Q1 revenue rises 15% to Rs 3,942 crore
August 7, 2025 at 03:00 PM UTC•By FilingReader AI
Biocon Limited reported Q1FY26 operating revenue of Rs 3,942 crore, up 15% year-on-year, with EBITDA growing 19% to Rs 829 crore.
Biosimilars drove growth with 18% revenue increase to Rs 2,458 crore. CRDMO revenue rose 11% to Rs 875 crore and Generics increased 6% to Rs 697 crore. Profit before tax surged 72% to Rs 97 crore.
The company completed a qualified institutions placement in June 2025, raising Rs 4,500 crore.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
BSE:BIOCON•Bombay Stock Exchange
News Alerts
Get instant email alerts when Biocon publishes news
Free account required • Unsubscribe anytime